Fei Yu

1.4k total citations · 1 hit paper
64 papers, 968 citations indexed

About

Fei Yu is a scholar working on Radiology, Nuclear Medicine and Imaging, Electrical and Electronic Engineering and Neurology. According to data from OpenAlex, Fei Yu has authored 64 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Electrical and Electronic Engineering and 9 papers in Neurology. Recurrent topics in Fei Yu's work include Cardiac Imaging and Diagnostics (8 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Photonic and Optical Devices (6 papers). Fei Yu is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Photonic and Optical Devices (6 papers). Fei Yu collaborates with scholars based in China, United States and Switzerland. Fei Yu's co-authors include Jian Hai, Shao-Hua Su, Yi‐Fang Wu, Yu‐Shui Ma, Da Fu, Likun Hou, Chunyan Wu, Haimin Lu, Xiaomei Tang and Jibin Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Fei Yu

58 papers receiving 946 citations

Hit Papers

Liquid biopsy in lung cancer: significance in diagnostics... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Yu China 16 284 230 201 160 156 64 968
Niloufar Sadeghi Belgium 19 327 1.2× 398 1.7× 487 2.4× 91 0.6× 185 1.2× 69 1.5k
Donald Macarthur United Kingdom 20 196 0.7× 103 0.4× 270 1.3× 76 0.5× 107 0.7× 53 1.2k
Matthias Krause Germany 15 174 0.6× 161 0.7× 175 0.9× 36 0.2× 137 0.9× 88 1.0k
Zhang Xue-lin China 17 254 0.9× 347 1.5× 64 0.3× 227 1.4× 161 1.0× 54 1.0k
Muhammad M. Abd‐El‐Barr United States 24 438 1.5× 97 0.4× 280 1.4× 53 0.3× 85 0.5× 145 2.0k
Bo Gao China 16 180 0.6× 412 1.8× 89 0.4× 50 0.3× 114 0.7× 70 1.2k
Joseph Megyesi Canada 22 283 1.0× 208 0.9× 544 2.7× 182 1.1× 337 2.2× 57 1.5k
Rainer Ritz Germany 22 184 0.6× 225 1.0× 292 1.5× 77 0.5× 299 1.9× 53 1.2k
Giovanni Morana Italy 25 273 1.0× 450 2.0× 465 2.3× 107 0.7× 339 2.2× 145 1.8k

Countries citing papers authored by Fei Yu

Since Specialization
Citations

This map shows the geographic impact of Fei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yu more than expected).

Fields of papers citing papers by Fei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yu. The network helps show where Fei Yu may publish in the future.

Co-authorship network of co-authors of Fei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yu. A scholar is included among the top collaborators of Fei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yu. Fei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xian, Yelin Wu, Jiajia Zhang, et al.. (2025). Self‐Powered α Radionuclide Nanomedicine: Mitochondria‐Targeted Multimodal Energy Recycling for Amplified Radioimmunotherapy. Advanced Materials. 37(37). e2504612–e2504612.
2.
Zhang, Jiajia, Shanshan Qin, Fengyuan Hu, et al.. (2025). Preclinical evaluation of [211At]At-AuNP-ABDMPL16 for targeted alpha therapy in Melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4497–4510.
3.
Song, Zhiling, Jiajia Zhang, Shanshan Qin, et al.. (2025). Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions. European Journal of Nuclear Medicine and Molecular Imaging. 53(1). 30–47. 2 indexed citations
5.
Zheng, Qingqing, Yi Guo, Yuwei Xia, et al.. (2024). Automatic detection of cognitive impairment in patients with white matter hyperintensity and causal analysis of related factors using artificial intelligence of MRI. Computers in Biology and Medicine. 178. 108684–108684. 7 indexed citations
6.
Huang, Yan, Han Zhang, Shanshan Qin, et al.. (2024). The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes. EJNMMI Physics. 11(1). 5–5.
7.
Yang, Mengdie, Jianguo Li, Xiaoyi Zhang, et al.. (2024). Layered Double Hydroxides for Radium‐223 Targeted Alpha Therapy with Elicitation of the Immune Response. Advanced Healthcare Materials. 14(3). e2403175–e2403175. 1 indexed citations
8.
Zhu, Mengqin, Han Zhang, Hanhui Liu, et al.. (2024). The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases. Biomedicines. 12(3). 532–532. 1 indexed citations
9.
Zhu, Mengqin, Jiajia Zhang, Mengdie Yang, et al.. (2023). In vitro and in vivo study on the treatment of non-small cell lung cancer with radionuclide labeled PD-L1 nanobody. Journal of Cancer Research and Clinical Oncology. 149(11). 8429–8442. 8 indexed citations
10.
Yang, Mengdie, Haipeng Liu, Jiajia Zhang, et al.. (2023). Alpha‐Emitter Radium‐223 Induces STING‐Dependent Pyroptosis to Trigger Robust Antitumor Immunity. Small. 20(9). e2307448–e2307448. 14 indexed citations
11.
Zhang, Han, Federico Caobelli, Wenliang Che, et al.. (2023). The prognostic value of CZT SPECT myocardial blood flow (MBF) quantification in patients with ischemia and no obstructive coronary artery disease (INOCA): a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 1940–1953. 12 indexed citations
12.
Zhang, Jiajia, et al.. (2023). Alpha‐emitters and targeted alpha therapy in cancer treatment. SHILAP Revista de lepidopterología. 1(3). 245–261. 9 indexed citations
13.
Qin, Shanshan, Yuanyou Yang, Jiajia Zhang, et al.. (2023). Effective Treatment of SSTR2-Positive Small Cell Lung Cancer Using 211At-Containing Targeted α-Particle Therapy Agent Which Promotes Endogenous Antitumor Immune Response. Molecular Pharmaceutics. 20(11). 5543–5553. 21 indexed citations
14.
Wang, Zhengshi, et al.. (2023). A Proposed Modified Staging System for Medullary Thyroid Cancer: A SEER Analysis With Multicenter Validation. The Oncologist. 29(1). e59–e67. 9 indexed citations
15.
Huang, Yan, Han Zhang, Xin Fan, et al.. (2022). The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases. Journal of Cardiovascular Translational Research. 16(3). 581–589. 22 indexed citations
16.
Chávez, Germán, Colin A. McCannel, Peter A. Quirós, et al.. (2021). Prospective, Randomized Trial Comparing Simulator-based versus Traditional Teaching of Direct Ophthalmoscopy for Medical Students. American Journal of Ophthalmology. 238. 187–196. 10 indexed citations
17.
Ma, Mingyu, et al.. (2020). Discharge characteristics of pin-micron droplet-pin system driven by DC pulse voltage. Journal of Physics D Applied Physics. 53(22). 225203–225203. 4 indexed citations
18.
Li, Lijun, et al.. (2019). 1.5 μm spectral band laser power modulation multilayer graphene refractive index. Optics & Laser Technology. 119. 105676–105676.
19.
Li, Gang, Chao Li, Junjie Xie, et al.. (2018). Experience in diagnosis and treatment of infection and bleeding caused by DCD-derived CRKP in kidney transplant recipients. 39(10). 582–585. 1 indexed citations
20.
Kanda, Tsugiyasu, Jun-ichi Yamakawa, Junji Moriya, et al.. (2005). Globalization of Kampo Medicine. 30(4). 297–301. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026